|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RESEARCH-ARTICLE |
D Zieba, Sheep and Goat Breeding, Agricultural University, Krakow, Poland
M Szczesna, Sheep and Goat Breeding, Agricultural University, Krakow, Poland
B Klocek-Gorka, Sheep and Goat Breeding, Agricultural University, Krakow, Poland
E Molik, Sheep and Goat Breeding, Agricultural University, Krakow, Poland
T Misztal, Endocrinology, Polish Academy of Sciences, Jablonna, Poland
G Williams, Animal Science, Texas A&M University, Beeville, United States
K Romanowicz, Endocrinology, Polish Academy of Sciences, Jablonna, Poland
E Stepien, Independent Laboratory of Molecular Biology and Research, John Paul II Hospital, Krakow, Poland
D Keisler, Animal Science, University of Missouri, Columbia, United States
M Murawski, Sheep and Goat Breeding, Agricultural University, Krakow, Poland
Correspondence: Dorota Zieba, Email: rzzieba{at}cyf-kr.edu.pl
Abstract
Recent studies have demonstrated photoperiodic changes in leptin sensitivity of seasonal mammals. Herein we examined the interaction of season (long-; LD vs short-day; SD) and recombinant ovine leptin (roleptin) on melatonin and prolactin (PRL) secretions and mRNA expression of suppressor of cytokine signaling-3 (SOCS-3) in the mediobasal-arcuate nucleus (MB-ARC) region in sheep. Ewes (n=24), were utilized in a replicated switchback design involving 12 ewes/season and were assigned randomly to one of three groups. Ewes were infused intracerebrventricularly 3 times with following treatments: 1) Control, 2) L1; roleptin, 0.5 µg/kg BW, and 3) L2; roleptin, 1.0 µg/kg BW. Jugular blood samples were collected every 15-minute intervals for 6 hours. At the conclusion of sampling, a washout period (about 3 days) elapsed before ewes were re-randomized and the treatments were repeated. Ewes were then euthanized and MB-ARC were collected for RT-PCR processing. Leptin treatments increased (P < 0.001) circulating leptin concentrations vs controls during both seasons. Overall mean plasma melatonin concentrations were greater (P < 0.001) during LD than SD. However, leptin treatments increased melatonin concentrations during SD in a dose-dependent manner and decreased it during LD. Circulating PRL decreased (P < 0.001) in response to leptin during LD. Leptin increased (P < 0.001) SOCS-3 expression in MB-ARC during LD in a dose-dependent manner. Data provide evidence that melatonin and PRL secretions are inversely regulated by leptin during SD and LD. However, the increase in expression of SOCS-3 in the MB-ARC during LD compared to SD fails to fully explain these effects.
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH |